Société Edge Therapeutics Inc Nasdaq
Actions
US2798701098
Recherche biotechnologique et médicale
Métier
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Frank Bedu-Addo
FOU | Founder | 59 | 15/03/19 |
Director of Finance/CFO | 55 | 04/12 | |
David Schaaf
CTO | Chief Tech/Sci/R&D Officer | - | 01/09/22 |
Spencer Brown
CMP | Compliance Officer | 54 | 01/06/22 |
Gregory Conn
CTO | Chief Tech/Sci/R&D Officer | 69 | 01/01/05 |
Joe J. Dervan
CTO | Chief Tech/Sci/R&D Officer | - | - |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Stephen Glover
CHM | Chairman | 60 | 02/04/19 |
Otis Brawley
BRD | Director/Board Member | 64 | 03/11/20 |
Richard Sykes
BRD | Director/Board Member | 79 | 01/03/19 |
Director/Board Member | 65 | 21/02/20 | |
Gregory Freitag
BRD | Director/Board Member | 62 | 01/03/19 |
Frank Bedu-Addo
FOU | Founder | 59 | 15/03/19 |
Ilian Iliev
BRD | Director/Board Member | 48 | 08/04/20 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 36 679 275 | 35 209 588 ( 95,99 %) | 0 | 95,99 % |
Coordonnées société
Secteur
Varia. 1 janv. | Capi. | |
---|---|---|
+8,15% | 113 Md | |
+10,45% | 106 Md | |
+0,41% | 22,27 Md | |
-12,04% | 22,22 Md | |
-5,99% | 19,43 Md | |
-37,36% | 17,87 Md | |
-5,81% | 17,24 Md | |
+7,48% | 14,29 Md | |
+37,15% | 12,52 Md |